| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 04/04/2000 | US6046329 Uracil derivatives |
| 04/04/2000 | US6046215 A piperidinylbenzothiophenes useful for trating brain disorders |
| 04/04/2000 | US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 04/04/2000 | US6046210 Antipsychotic agents |
| 04/04/2000 | US6046205 For treatment of venous insufficiency and of associated disorders, and also in the treatment of migraine |
| 04/04/2000 | US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus |
| 04/04/2000 | US6046203 Useful for the treatment of various memory dysfunctions characterized by a decreased cholinergic function such as alzheimer's disease; also inhibit monoamine oxidase and hence are useful as antidepressants |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046193 Treatment of attention-deficit/hyperactivity disorder |
| 04/04/2000 | US6046183 Synergistic mixture of finasteride and doxazosin |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046170 Therapeutic use of hemoglobin to treat head injury |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046022 Methods and compositions employing red rice fermentation products |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 04/04/2000 | US6045807 Method for production of neuroblasts |
| 04/04/2000 | US6045792 Human proteins kinases |
| 04/04/2000 | US6045398 Battery accepting unit and battery pack |
| 04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
| 04/04/2000 | CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
| 04/04/2000 | CA1340943C Azacyclic compounds and their preparation and use |
| 03/30/2000 | WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017358A2 Human chaperone proteins |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017201A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| 03/30/2000 | WO2000017198A1 3-bicycloindole compounds as 5-ht1d ligands |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/30/2000 | WO2000017161A1 Cyclic ester or amide derivatives |
| 03/30/2000 | WO2000017143A1 Derivatives of phenantrene for medicinal use and a process for their preparation |
| 03/30/2000 | WO2000016800A2 Methods of treating chronic pain |
| 03/30/2000 | WO2000016799A1 Methods of treating chronic pain |
| 03/30/2000 | WO2000016797A2 Use of glp-1 or analogs in treatment of stroke |
| 03/30/2000 | WO2000016794A1 Neuroimmunophilins for selective neuronal radioprotection |
| 03/30/2000 | WO2000016790A1 Defined extracts of eschscholzia californica with a minimum alkaloid content, production and use thereof in the production of pain-relieving medicaments |
| 03/30/2000 | WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations |
| 03/30/2000 | WO2000016777A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000016751A1 Fentanyl composition for the treatment of acute pain |
| 03/30/2000 | WO2000016750A1 Pharmaceutical composition for the treatment of acute disorders |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | WO2000000120A9 Methods and transdermal compositions for pain relief |
| 03/30/2000 | WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/30/2000 | WO1999061066A9 Convection-enhanced delivery of aav vectors |
| 03/30/2000 | WO1999053055A3 Therapeutic agent for ngf |
| 03/30/2000 | DE19856261C1 Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors |
| 03/30/2000 | DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations |
| 03/30/2000 | DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments |
| 03/30/2000 | CA2820588A1 Pharmaceutical composition for the treatment of acute disorders |
| 03/30/2000 | CA2629988A1 Pharmaceutical composition for the treatment of acute disorders |
| 03/30/2000 | CA2345378A1 Neuroimmunophilins for selective neuronal radioprotection |
| 03/30/2000 | CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | CA2344828A1 ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives |
| 03/30/2000 | CA2344670A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2344056A1 Use of glp-1 or analogs in treatment of stroke |
| 03/30/2000 | CA2343391A1 3-bicycloindole compounds as 5-ht1d ligands |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/30/2000 | CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/30/2000 | CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | CA2341036A1 Cyclic ester or amide derivatives |
| 03/30/2000 | CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/29/2000 | EP0989155A1 Powdery modified fillers containing rubber powder, method for the production and use thereof |
| 03/29/2000 | EP0988379A1 Ldl-receptor |
| 03/29/2000 | EP0988320A1 Cyclic crf agonists |
| 03/29/2000 | EP0988306A1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same |
| 03/29/2000 | EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 03/29/2000 | EP0988035A1 Caspases and apoptosis |
| 03/29/2000 | EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses |
| 03/29/2000 | CN1248973A Oxazolidines as 5-HT2A-antagonists |
| 03/29/2000 | CN1248971A Quinoxalinediones |
| 03/29/2000 | CN1248439A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system |
| 03/29/2000 | CN1050844C Protein kinase C inhibitors |
| 03/29/2000 | CN1050841C Indole derivatives and medicinal composition having same |
| 03/29/2000 | CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors |
| 03/29/2000 | CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use |